High cardiovascular health was associated with a reduced effect of insulin resistance on all-cause and cardiovascular mortality risk.

The FDA approved 3 new color additives, a move that will provide manufacturers with a wider range of natural color options to safely be used in food.

A Cornell University project to save babies born with serious heart defects has lost key funding just days after it was approved.

Topline results were announced from a phase 3 study comparing aficamten with metoprolol in adults with symptomatic obstructive hypertrophic cardiomyopathy.

The FDA has approved HemiClor (12.5 mg chlorthalidone) tablets for the treatment of hypertension in adults, to lower blood pressure.